Company Filing History:
Years Active: 2024-2025
Title: Julie Marie-Pomme Gabrielle Milojevic: Innovator in Hematology
Introduction
Julie Marie-Pomme Gabrielle Milojevic is a prominent inventor based in Village Neuf, France. She has made significant contributions to the field of hematology, particularly in the treatment of paroxysmal nocturnal hemoglobinuria (PNH). With a total of 2 patents, her work is recognized for its innovative approaches to medical treatment.
Latest Patents
Milojevic's latest patents focus on the use of factor B inhibitors. The first patent describes methods of treating PNH with the Factor B inhibitor LNP023 or a pharmaceutically acceptable salt thereof, such as LNP023 hydrochloride. The second patent reiterates similar methods, emphasizing the importance of this treatment in managing PNH effectively.
Career Highlights
Julie is currently associated with Novartis AG, a leading global healthcare company. Her role at Novartis has allowed her to further her research and development efforts in innovative treatments for blood disorders. Her expertise and dedication have positioned her as a key figure in her field.
Collaborations
Milojevic has collaborated with notable colleagues, including Irina Baltcheva and Peter End. These partnerships have enhanced her research capabilities and contributed to the advancement of her projects.
Conclusion
Julie Marie-Pomme Gabrielle Milojevic is a trailblazer in the field of hematology, with her innovative patents paving the way for new treatments for PNH. Her work continues to impact the medical community positively.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.